Rustgi, Vinod K <br/><br/>
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Dec 2009 
 - 1719-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.23204  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Carbamates--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Phenylurea Compounds--administration & dosage<br/>Polyethylene Glycols--administration & dosage<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage